Cloud Stocks: Veeva Sees Customer Momentum


According to a Research and Markets report, the global healthcare cloud computing market is expected to grow at 17% CAGR to $51.9 billion by 2024 as companies continue to adopt big data analytics and IoT in healthcare. Veeva (NYSE: VEEV) recently reported its quarterly results that continued to surpass all market expectations.

Veeva’s Financials

Veeva’s Q3 revenues grew 34% over the year to $377.5 million, ahead of the Street’s forecast of $361.86 million. On an adjusted basis, EPS was $0.78, surpassing the Street’s estimates of $0.68.

By segment, revenues from subscription services grew 34% to $302.9 million. Professional services revenues grew 37.7% to $74.6 million.

With strong products and focus on reference selling, Veeva scored an impressive gain of 19 new CRM customers. Commercial cloud revenue grew 32% to $152 million and Vault revenue grew 35% to $151 million.

For the current quarter, Veeva forecast revenues of $378-$380 million with an adjusted EPS of $0.67-$0.68. The market was looking for revenues of $347.3 million with an EPS of $0.45. Veeva expects to end the current year with revenues of $1.446-$1.448 billion and an EPS of $2.83-$2.84. The market was looking for revenues of $1.39 billion with an adjusted EPS of $1.80 for the year.

Veeva’s Product Upgrades

During the quarter, Veeva announced several new products. Veeva Site Connect was released as its first Clinical Network application that will be able to connect sites and sponsors. The service automates the flow of trial information between Veeva Clinical applications that is used by sponsors and CROs, and Veeva SiteVault, a compliant eISF application for clinical research sites. Veeva Site Connect will allow study partners to streamline information sharing across end-to-end trial processes for better collaboration and faster trials.

Earlier last month, it announced Veeva Link for 11 new therapeutic areas. Veeva Link will connect scientific, clinical, and digital activities to provide commercial and medical teams real-time customer intelligence on key people by therapeutic area. Prior to the launch of these new therapeutic areas, Veeva Link was already available for Oncology and has been used by six of the top 10 largest pharmaceutical companies. Veeva Link gathers information from more than 50,000 sources and manages it in real-time through advanced technology and human curation. Veeva Link helps field teams to have access to fast, complete, and accurate intelligence from planning to execution.

1 2
View single page >> |

Sramana Mitra is the founder of One Million by One Million (1M/1M), a global virtual incubator that aims to help one million entrepreneurs ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.